A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01121640
Recruitment Status : Active, not recruiting
First Posted : May 12, 2010
Last Update Posted : August 21, 2017
The Marsha Rivkin Center for Ovarian Cancer Research
Canary Foundation
Swedish Medical Center
City of Hope Medical Center
Cedars-Sinai Medical Center
Stanford University
Fox Chase Cancer Center
Information provided by (Responsible Party):
Fred Hutchinson Cancer Research Center